193 related articles for article (PubMed ID: 30053293)
1. Protection against duck hepatitis a virus type 1 conferred by a recombinant avian adeno-associated virus.
Wang AP; Liu L; Gu LL; Guo CM; Wu S; Feng Q; Xia WL; Wu Z; Zhu SY
Poult Sci; 2019 Jan; 98(1):112-118. PubMed ID: 30053293
[TBL] [Abstract][Full Text] [Related]
2. Expression of duck hepatitis A virus type 1 VP3 protein mediated by avian adeno-associated virus and its immunogenicity in ducklings.
Wang AP; Liu L; Gu LL; Wu S; Guo CM; Feng Q; Xia WL; Yuan C; Zhu SY
Acta Virol; 2019; 63(1):53-59. PubMed ID: 30879313
[TBL] [Abstract][Full Text] [Related]
3. Recombinant VP1 protein of duck hepatitis virus 1 expressed in Pichia pastoris and its immunogenicity in ducks.
Wang C; Li XK; Wu TC; Wang Y; Zhang CJ; Cheng XC; Chen PY
Acta Virol; 2014; 58(4):333-9. PubMed ID: 25518714
[TBL] [Abstract][Full Text] [Related]
4. Protective efficacy of a bivalent live attenuated vaccine against duck hepatitis A virus types 1 and 3 in ducklings.
Kang M; Roh JH; Jang HK
Vet Microbiol; 2018 Feb; 214():108-112. PubMed ID: 29408021
[TBL] [Abstract][Full Text] [Related]
5. Pathogenicity of duck hepatitis A virus type 3 and innate immune responses of the ducklings to virulent DHAV-3.
Zhang X; Cao C; Qu Z; Zhang W; Liu Y; Qi H; Hao C; Zhang W; Gao M; Wang J; Ma B
Mol Immunol; 2018 Mar; 95():30-38. PubMed ID: 29407574
[TBL] [Abstract][Full Text] [Related]
6. Protective immune responses in ducklings induced by a suicidal DNA vaccine of the VP1 gene of duck hepatitis virus type 1.
Fu Y; Chen Z; Li C; Liu G
Vet Microbiol; 2012 Dec; 160(3-4):314-8. PubMed ID: 22819169
[TBL] [Abstract][Full Text] [Related]
7. Efficient production of an avian adeno-associated virus vector using insect cell/baculovirus expression system.
Wang A; Wang Y; Wu S; Zuo W; Guo C; Hong W; Zhu S
J Virol Methods; 2017 Feb; 240():26-31. PubMed ID: 27867046
[TBL] [Abstract][Full Text] [Related]
8. [Development and evaluation of an inactivated bivalent vaccine against duck viral hepatitis].
Yin F; Jing L; Zhang S; Yu M; Zhang W; Fan G; Dong X; Liu W
Sheng Wu Gong Cheng Xue Bao; 2015 Nov; 31(11):1579-88. PubMed ID: 26939441
[TBL] [Abstract][Full Text] [Related]
9. Molecular epidemiology of duck hepatitis a virus types 1 and 3 in China, 2010-2015.
Wen X; Zhu D; Cheng A; Wang M; Chen S; Jia R; Liu M; Sun K; Zhao X; Yang Q; Wu Y; Chen X
Transbound Emerg Dis; 2018 Feb; 65(1):10-15. PubMed ID: 29076646
[TBL] [Abstract][Full Text] [Related]
10. Development of duck hepatitis A virus type 3 vaccine and its use to protect ducklings against infections.
Kim MC; Kim MJ; Kwon YK; Lindberg AM; Joh SJ; Kwon HM; Lee YJ; Kwon JH
Vaccine; 2009 Nov; 27(48):6688-94. PubMed ID: 19747575
[TBL] [Abstract][Full Text] [Related]
11. Study on the expression of human lysozyme in oviduct bioreactor mediated by recombinant avian adeno-associated virus.
Wang AP; Wang YJ; Wu S; Zuo WY; Guo CM; Hong WM; Zhu SY
Poult Sci; 2017 Jul; 96(7):2447-2453. PubMed ID: 28339926
[TBL] [Abstract][Full Text] [Related]
12. [Indirect ELISA for simultaneous detection of antibodies against duck hepatitis A type 1 and 3 viruses].
Zhang Y; Ma X; Huang B; Li Y; Yu K; Li J; Liu C; Han H; Cui Y
Wei Sheng Wu Xue Bao; 2015 Apr; 55(4):501-9. PubMed ID: 26211325
[TBL] [Abstract][Full Text] [Related]
13. Identification of a conserved neutralizing linear B-cell epitope in the VP1 proteins of duck hepatitis A virus type 1 and 3.
Zhang R; Zhou G; Xin Y; Chen J; Lin S; Tian Y; Xie Z; Jiang S
Vet Microbiol; 2015 Nov; 180(3-4):196-204. PubMed ID: 26427545
[TBL] [Abstract][Full Text] [Related]
14. Protection against infectious bursal disease virulent challenge conferred by a recombinant avian adeno-associated virus vaccine.
Perozo F; Villegas P; Estevez C; Alvarado IR; Purvis LB; Williams S
Avian Dis; 2008 Jun; 52(2):315-9. PubMed ID: 18646463
[TBL] [Abstract][Full Text] [Related]
15. [Inhibition of infectious bursal disease virus replication in chicken embryos by miRNAs delivered by recombinant avian adeno-associated viral vector].
Shen P; Wang Y; Sun H; Zhang X; Xia X
Wei Sheng Wu Xue Bao; 2011 Feb; 51(2):256-61. PubMed ID: 21574388
[TBL] [Abstract][Full Text] [Related]
16. Evidence of possible vertical transmission of duck hepatitis A virus type 1 in ducks.
Zhang R; Yang Y; Lan J; Xie Z; Zhang X; Jiang S
Transbound Emerg Dis; 2021 Mar; 68(2):267-275. PubMed ID: 32598568
[TBL] [Abstract][Full Text] [Related]
17. First Report of Duck Hepatitis A Virus 3 from Duckling Flocks of Egypt.
Hassan TIR; Eid AAM; Ghanem IAI; Shahin AM; Adael SAA; Mohamed FF
Avian Dis; 2020 Sep; 64(3):269-276. PubMed ID: 33205161
[TBL] [Abstract][Full Text] [Related]
18. Dual Circulation of Duck Hepatitis A Virus Genotypes 1 and 3 in Egypt.
Yehia N; Erfan AM; Omar SE; Soliman MA
Avian Dis; 2021 Mar; 65(1):1-9. PubMed ID: 34339115
[TBL] [Abstract][Full Text] [Related]
19. Detection, differentiation, and VP1 sequencing of duck hepatitis A virus type 1 and type 3 by a 1-step duplex reverse-transcription PCR assay.
Wen XJ; Cheng AC; Wang MS; Jia RY; Zhu DK; Chen S; Liu MF; Liu F; Chen XY
Poult Sci; 2014 Sep; 93(9):2184-92. PubMed ID: 25012848
[TBL] [Abstract][Full Text] [Related]
20. Live attenuated duck hepatitis virus vaccine in breeder ducks: Protective efficacy and kinetics of maternally derived antibodies.
Roh JH; Kang M
Vet Microbiol; 2018 Jun; 219():107-112. PubMed ID: 29778181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
